Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?

Abstract:

:There is difficulty in obtaining adequate supplies of blood components, as well as disappointing performance of stabilized or recombinant hemoglobins, limited indications of oxygen transporters (perfluorocarbons), and slow development of "universal" red blood cells (RBCs). There is, therefore, a need for complementary sources of RBCs for transfusion. Thus, an attempt to generate erythroid cells in vitro makes good sense. We describe in this article a methodology permitting the massive ex vivo production of mature human RBCs having all the characteristics of native adult RBCs from hematopoietic stem cells of diverse origins: blood, bone marrow, or cord blood. This protocol allows both the massive expansion of hematopoietic stem cells/progenitors and their complete differentiation to the stage of perfectly functional mature RBCs. The levels of amplification obtained (10(5) to 2 x 10(6)) are compatible with an eventual transfusion application. We discuss in this article the state of the art of this new concept and evoke possible obstacles that need to be overcome to pass from a laboratory model to clinical practice. We analyze its possible indications in the medium and long term, discuss the economic aspects, and raise the question: Can we afford the luxury of developing this approach, one that could represent a considerable advance in blood transfusion?

journal_name

Transfus Med Rev

authors

Douay L,Andreu G

doi

10.1016/j.tmrv.2006.11.004

subject

Has Abstract

pub_date

2007-04-01 00:00:00

pages

91-100

issue

2

eissn

0887-7963

issn

1532-9496

pii

S0887-7963(06)00093-9

journal_volume

21

pub_type

杂志文章,评审
  • Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies.

    abstract::Significant progress has been made in reducing the risk of pathogen transmission to transfusion recipients. Nonetheless, there remains a continuing risk of transmission of viruses, bacteria, protozoa, and prions to recipients. These include many of the viruses for which specific screening tests exist as well as pathog...

    journal_title:Transfusion medicine reviews

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1016/j.tmrv.2007.09.001

    authors: Webert KE,Cserti CM,Hannon J,Lin Y,Pavenski K,Pendergrast JM,Blajchman MA

    更新日期:2008-01-01 00:00:00

  • Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review.

    abstract::The use of prothrombin complex concentrates (PCCs) and fibrinogen concentrates (FIBCs) to achieve hemostasis in the perioperative setting as alternatives to allogeneic blood products remains controversial. To examine the efficacy and safety of PCCs and FIBCs, we conducted a systematic review-in accordance with the Pre...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2013.01.002

    authors: Lin DM,Murphy LS,Tran MH

    更新日期:2013-04-01 00:00:00

  • Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma.

    abstract::In summary, it is impossible to reconcile the contradictory results of the studies of the association between previous blood transfusion and subsequent development of NHL (Figs 1 and 2). Most of the studies were of high quality, and the authors discussed the possible sources of bias that might have generated a spuriou...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1053/tm.20000.7395

    authors: Vamvakas EC

    更新日期:2000-07-01 00:00:00

  • Platelet Immunology in China: Research and Clinical Applications.

    abstract::Immunization against human platelet alloantigens (HPAs) is associated with a number of clinical complications. The detection and identification of clinically relevant platelet antibodies are important for the diagnosis and management of patients affected with immune-mediated thrombocytopenias. Human platelet alloantig...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2016.12.001

    authors: Wu G,Zhou Y,Li L,Zhong Z,Li H,Li H,Yu M,Shen W,Ni H

    更新日期:2017-04-01 00:00:00

  • The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety.

    abstract::Although the true risk of transmitting (classical) Creutzfeld-Jakob Disease (CJD) and variant CJD (vCJD) via transfusion is likely very minimal, a review of prions and the impact of these associated prion diseases is timely because of their current effect on safety policies in the blood-plasma industry. Various types ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1053/tm.2001.25382

    authors: Hoots WK,Abrams C,Tankersleydagger D

    更新日期:2001-04-01 00:00:00

  • Hemostatic and signaling functions of transfused platelets.

    abstract::Metabolic studies have revealed a gradual impairment in platelet integrity during storage, a process termed the platelet storage lesion. Recent evidence shows that stored platelets also lose signaling responses to physiological agonists with impaired integrin activation, secretion, and aggregation of the cells. On the...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2007.05.004

    authors: Cauwenberghs S,van Pampus E,Curvers J,Akkerman JW,Heemskerk JW

    更新日期:2007-10-01 00:00:00

  • Passenger Lymphocyte Syndrome; a Review of the Diagnosis, Treatment, and Proposed Detection Protocol.

    abstract::Passenger lymphocyte syndrome (PLS) is caused by the transfer of B-lymphocytes present in the donor graft into the recipient circulation following solid organ or hematopoietic stem cell transplantation. These cells may produce antibodies against the recipient's red blood cells, thereby triggering antibody dependent cy...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2020.06.004

    authors: Moosavi MM,Duncan A,Stowell SR,Roback JD,Sullivan HC

    更新日期:2020-07-01 00:00:00

  • Platelet derivatives in regenerative medicine: an update.

    abstract::Prior preclinical and clinical studies support the use of platelet-derived products for the treatment of soft and hard tissue lesions. These regenerative effects are controlled by autocrine and paracrine biomolecules including growth factors and cytokines contained in platelet alpha granules. Each growth factor is inv...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2014.11.001

    authors: De Pascale MR,Sommese L,Casamassimi A,Napoli C

    更新日期:2015-01-01 00:00:00

  • Does hybridoma technology still have a place in transfusion medicine?

    abstract::Hybridoma technology has contributed to virtually all areas of biology and medicine and set the scene for important advances in cell biology and immunodiagnostics. Blood transfusion and transfusion medicine have benefited significantly from development in hybridoma technology, and this has resulted in the generation o...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1053/tmrv.2002.33436

    authors: Yuan FF,Watt JM,Geczy AF

    更新日期:2002-07-01 00:00:00

  • The fibrinolytic system-more than fibrinolysis?

    abstract::The fibrinolytic system, known for its ability to regulate the activation of the zymogen plasminogen into active plasmin, has been primarily associated with the removal of fibrin and blood clots. Tissue-type plasminogen activator, the most well-recognized plasminogen activator, was harnessed for therapeutic benefit ag...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2014.09.006

    authors: Draxler DF,Medcalf RL

    更新日期:2015-04-01 00:00:00

  • In vitro assessment of platelet function.

    abstract::With the realization that the skin bleeding time is often an unreliable measure of platelet function, efforts have been made to identify ways to assess qualitative platelet dysfunction. Currently available techniques measure platelet adhesion, platelet aggregation, the ability of platelets to retard or stop flow throu...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1053/tm.1997.0110106

    authors: Carr ME Jr

    更新日期:1997-04-01 00:00:00

  • Cost-effectiveness analysis: what it really means for transfusion medicine decision making.

    abstract::Some have suggested that "blood is different," and the role for cost-effectiveness is thus circumscribed. In this article, the authors start by reviewing key concepts in health economics and economic analysis methods. Examples are drawn from published blood safety studies. After explaining the underlying reasoning beh...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2008.09.001

    authors: Custer B,Hoch JS

    更新日期:2009-01-01 00:00:00

  • The structure and function of the molecules that carry human red blood cell and platelet antigens.

    abstract::A number of molecules on the surface of red blood cells (RBCs) and platelets express antigenic activity. Various biochemical and molecular approaches have been used to determine the structure and possible function that these molecules have for their respective cell types. The existence of variant molecules and null ph...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2004.03.006

    authors: Denomme GA

    更新日期:2004-07-01 00:00:00

  • Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.

    abstract::Despite significant advancements in the production of platelet products, storage, and transfusion, transfusion refractoriness remains a significant clinical problem, affecting up to 14% of hematological patients receiving platelet transfusions. Human leukocyte antigen (HLA) alloimmunization is a major cause of immune ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2020.09.010

    authors: Saris A,Pavenski K

    更新日期:2020-10-01 00:00:00

  • The challenge of platelet alloimmunization: management and prevention.

    abstract::The limiting factor in platelet transfusion therapy is the development of alloimmunization. Although using HLA matched platelets may be effective in reducing the problem of alloimmune platelet transfusion refractoriness, relying solely upon HLA matching has its shortcomings. The selection of compatible platelet transf...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(90)70237-4

    authors: Kickler TS

    更新日期:1990-10-01 00:00:00

  • Drivers of transfusion decision making and quality of the evidence in orthopedic surgery: a systematic review of the literature.

    abstract::Reasons for variation in transfusion practice in orthopedic surgery are not well understood. This systematic review identified and appraised the quality of the literature in this area to assess the impact of factors associated with the use of allogeneic red blood cell (RBC) transfusion in orthopedic procedures. MEDLIN...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2011.04.003

    authors: Barr PJ,Donnelly M,Cardwell C,Alam SS,Morris K,Parker M,Bailie KE

    更新日期:2011-10-01 00:00:00

  • Neonatal Platelet Transfusions and Future Areas of Research.

    abstract::Thrombocytopenia affects approximately one fourth of neonates admitted to neonatal intensive care units, and prophylactic platelet transfusions are commonly administered to reduce bleeding risk. However, there are few evidence-based guidelines to inform clinicians' decision-making process. Developmental differences in...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2016.05.009

    authors: Sola-Visner M,Bercovitz RS

    更新日期:2016-10-01 00:00:00

  • Chromosome location of genes encoding human blood groups.

    abstract::The chromosomal locations of genes controlling the expression of some 200 antigens constituting the 23 established human blood group systems have been reviewed. Twenty-one of the these genes are located on 12 autosomes, and two are located on the X chromosome. Refined chromosomal positions, to a single cytogenetically...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(98)80056-4

    authors: Reid ME,McManus K,Zelinski T

    更新日期:1998-07-01 00:00:00

  • Virus inactivation in blood components by photoactive phenothiazine dyes.

    abstract::The virucidal properties of photoactive phenothiazine dyes, such as methylene blue, have been known approximately 70 years. The mechanism of virus inactivation involves binding of the dye to nucleic acid, absorption of light, generation of reactive oxygen species, guanine oxidation in the viral genome. The first pract...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1053/tmrv.2002.29405

    authors: Wagner SJ

    更新日期:2002-01-01 00:00:00

  • Is human herpesvirus-8 transmitted by transfusion?

    abstract::Studies of human herpesvirus-8 (HHV-8) transmission through transfusion have produced contradictory results. In North America-a region with a low prevalence of HHV-8 infection-3 studies that tested specimens from linked positive-donor/negative-recipient pairs collected before the introduction of white blood cell (WBC)...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2009.09.001

    authors: Vamvakas EC

    更新日期:2010-01-01 00:00:00

  • Metabolomics of ADSOL (AS-1) red blood cell storage.

    abstract::Population-based investigations suggest that red blood cells (RBCs) are therapeutically effective when collected, processed, and stored for up to 42 days under validated conditions before transfusion. However, some retrospective clinical studies have shown worse patient outcomes when transfused RBCs have been stored f...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章

    doi:10.1016/j.tmrv.2014.01.003

    authors: Roback JD,Josephson CD,Waller EK,Newman JL,Karatela S,Uppal K,Jones DP,Zimring JC,Dumont LJ

    更新日期:2014-04-01 00:00:00

  • Platelets are not just for clots.

    abstract::Although the role of platelets as central mediators of hemostasis and thrombosis has been the primary focus of research into platelet biology for more than a century, over the last decade, nonhemostatic functions of platelets have been increasingly defined. As such, a large body of experimental evidence now exists, wh...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2014.11.006

    authors: McFadyen JD,Kaplan ZS

    更新日期:2015-04-01 00:00:00

  • The management of blood safety in the presence of uncertain risk: a United kingdom perspective.

    abstract::Millions of patients in the UK benefit from the use of both plasma derivatives and blood components that are seen as critical interventions in current medicine. Measures are in place to significantly reduce the risks associated with blood transfusion and plasma derivatives; however, these measures themselves are not r...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2011.09.003

    authors: Watkins NA,Dobra S,Bennett P,Cairns J,Turner ML

    更新日期:2012-07-01 00:00:00

  • Cold agglutination.

    abstract::Autoantibodies against red cells optimally reacting at 0 degree C, ie, CA, are normally found with low titers in the serum of human adults. High-titer CA may be induced by certain infectious agents, including M pneumoniae, EBV, CMV, and rubella virus, or may develop on the basis of chronic (malignant) B cell lymphopro...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(89)70075-4

    authors: Roelcke D

    更新日期:1989-04-01 00:00:00

  • Putting the pieces together: Roger I. Lee and modern transfusion medicine.

    abstract::Roger Irving Lee (1881-1964) played significant scientific and leadership roles in overcoming the clinical impediments to blood transfusion in the 1910s. He developed the first successful anticoagulant system, paraffinized glass, and the first sterile system for indirect transfusion without defibrination, the Lee-Vinc...

    journal_title:Transfusion medicine reviews

    pub_type: 传,历史文章,杂志文章

    doi:10.1016/j.tmrv.2004.09.003

    authors: Stansbury LG,Hess JR

    更新日期:2005-01-01 00:00:00

  • Single- Versus Double-Unit Umbilical Cord Blood Transplantation for Hematologic Diseases: A Systematic Review.

    abstract::Controversial results exist regarding the clinical benefits of single- vs double-unit umbilical cord blood transplantation (UCBT) in patients with hematologic diseases. A systematic review was conducted to evaluate this issue. The PubMed, Embase, and Cochrane Library databases were searched up to May 2018. A total of ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章

    doi:10.1016/j.tmrv.2018.11.001

    authors: Wang L,Gu ZY,Liu SF,Ma DX,Zhang C,Liu CJ,Gao R,Guan LX,Zhu CY,Wang FY,Gao CJ,Wei HP

    更新日期:2019-01-01 00:00:00

  • What a difference 2 nucleotides make: a short review of ABO genetics.

    abstract::ABO is the most important blood group system for transfusion and solid organ transplantation, but it is only over the past 15 years that the techniques for studying its molecular basis became mainstream. Many of its common and rare alleles are now well characterized and by using various expression systems, their effec...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2005.02.003

    authors: Yazer MH

    更新日期:2005-07-01 00:00:00

  • Complement and Coagulation: Cross Talk Through Time.

    abstract::Two complex protein defense systems-complement and coagulation-are based on amplifying enzyme cascades triggered by specific local stimuli. Excess systemic activation of either system is pathologic and is normally prevented by a family of regulatory proteins. The 2 systems are ancient biological processes which share ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2019.08.004

    authors: Dzik S

    更新日期:2019-10-01 00:00:00

  • Donor deferral registries.

    abstract::In the last half of this century, donor deferral registries have grown in size, scope, and importance for blood collection organizations and regulatory agencies. This has occurred despite the lack of direct evidence that, when used with all other methods, they contribute meaningfully to the safety of the blood supply....

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(93)70131-5

    authors: Sherwood WC

    更新日期:1993-04-01 00:00:00

  • Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.

    abstract::Although the risk of infection by blood transfusion is relatively low, breakthrough infections still occur, Transfusion-related fatalities caused by infections continue to be reported, and blood is not tested for many potentially dangerous pathogens. The current paradigm for increasing the safety of the blood supply i...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2004.11.005

    authors: Allain JP,Bianco C,Blajchman MA,Brecher ME,Busch M,Leiby D,Lin L,Stramer S

    更新日期:2005-04-01 00:00:00